as the new Owner (Josh Sason)
it maybe best to clean house and bring in a seasoned Wall St. Bio-Pharma tycoon to take this to the very next level - provided the new Owner (Josh Sason) ran the numbers and did the proper feasibility analysis on the IP - to see if it actually warranted holding on to...
if it does not, as the new Owner (Josh Sason) may wish to chop it up and sell it in parts to the highest bidder - similar to what they do to a used car that has reached its useful and effective life - by sending it down to Mexico for parts
sober reality is that Gerald has placed us in here, as just some of the possibilities to consider - either way, AMBS is a very long way from any revenue or profitability whatsoever
sad but true...
AJMHO
News 
Market Data 
Discover 
